Author, Subjects, Keywords

Cited Author

 

 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » By Affiliations
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top 20 Journal Cited
 » Top 20 Cited
 » Top 20 Author Cited
 » Usage Since Sept 2007


 
 
 

Login | Create Account

The Genetics of Schizophrenia

Mohd. Rosli, S. (2004) The Genetics of Schizophrenia. Malaysian Journal of Medical Sciences, 11 (2). pp. 3-11. ISSN 1394195X

Full text not available from this repository.

Official URL: http://www.medic.usm.my/publication/mjms/

Affiliations

Universiti Sains Malaysia , School of Medical Sciences

Abstract

Schizophrenia is a complex biological disorder with multifactorial mode of transmission where non-genetic determinants are also play important role. It is
now clear that it involves combined effect of many genes, each conferring a small
increase in liability to the illness. Thus no causal disease genes or single gene of
major effects, only susceptible genes are operating. Given this complexity, it comes
as no surprise of the difficulty to find susceptible genes. However, schizophrenia
genes have been found at last. Recent studies on molecular genetics of schizophrenia
which focused on positional and functional candidate genes postulated to be
associated with schizophrenia are beginning to produce findings of great interest.
These include neuregulin (NRG-1, 8p12-21), dysbindin, (DTNBP1,6p22.3), G72
(13q34) / D-amino acid oxidase (DAAO,12q24), proline dehydrogenase (PRODH-
2, 22q11.21), catechol-O-methyltransferase (COMT, 22q11.21), regulator of G
protein signaling (RGS-4), 5HT2A and dopamine D3 receptor (DRD3). Applications of microarrays methods were able to locate positional candidate genes related to dopaminergic, serotonergic and glutamatergic neurotransmission. New genome scan project, seen in the light of previous scans, provide support for schizophrenia candidate region on chromosome 1q, 2q, 5q, 6p, 8p, 10p, 13q,15q and 22q. Other reports described including the application of LD mapping and positional cloning technique, microarray technology and efforts to develop quantitative phenotype. More exciting finding is expected in near future with the completion of Hap Mapproject.

Item Type:Journal
Keywords:schizophrenia, genetics, candidate gene, association study, linkage analysis
Subjects:R Medicine
ID Code:608

Jablenski A, Sartorius N, Ernberg G, et al. Schizophrenia: manifestation, incidence and course in different cultures. A World Health Organization Ten country study. Psychol Med Monograph 1992 (Suppl20).

Kety SS. Schizophrenic illness in the families of schizophrenic adoptees: findings from the Danish national sample. Schizophr Bull 1998; 14: 217-222.

Tsuang MT,Gilbertson MV, Farone SV. The genetic of schizophrenia: current knowledge and future directions. Schizophr Res 1991; 4:157-171.

Mowry BJ, Levinson DF. Genetic linkage in schizophrenia: method, recent findings and future direction. Aust N Z J Psychiatry 1993; 27:200-218..

Reich T, Clayton PJ, Winokour G. Family history studies: V. The genetics of mania. Am J Psychiatry 1969; 125: 1358-1369..

Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000; 405:847-956.

Malhotra AK, Goldman D. Benefits and pitfalls encountered in psychiatry genetic association studies.Biol Psychiatry 1999; 45:544-550.

Risch N, Teng J. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases: 1.DNA pooling.

Genome Res 1998; 8:1273-1286.

Shoemaker DD, Linsley PS. Recent developments in microarrays. Curr Opin Microbiol 2002; 5: 334-337.

Luo Z. Geschwind DH. Microarray applications in neuroscience. Neurobiol Dis 2001; 8: 183-103.

Owen M, O’Donovan M, Gottesman I. Schizophrenia.In: McGiffin P, Owen MJ, Gottesman II; eds. Psychiatric genetics and genomics. Oxford : Oxford. University Press; 2002.

Badner J, Gershon E. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002; 7: 405-411..

Levinson DF, Levinson MD, Segurdo R, Lewis CM. Genome scan meta-analysis of schizophrenia and bipolar disorder. Part1: Methods power and power analysis. Am J Human Genet 2003; 73: 17-33.

Riley BP, McGuffin P. Linkage and associated studies of schizophrenia. Am J Med Genet 2000; 97:23-44.

Risch N, Merikangas. The future of genetic studied of complex human disease. Science 1996; 273:1516-1517.

Elkin A, Kalidindi S, McGuffin P. Have schizophrenia genes been found?. Curr Opin Psychiatry 2004; 17:106-113.

Law A. Neuregulin -1 in the human brain. Am J Psychiatry 2003; 160:1392

Benson M, Newey S, Martin-Rebdon E, et al. Dysbindin, a novel coiled –coil-containing protein that interacts with the dystrobrevins in muscle and the brain.

J Biol Chem 2001; 276: 24232-24241.

Chumankov I, Blumenfield M, Guerassimenko O, et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002; 99:13675-13680.

Hattori E, Liu C, Badner JA, et al. Polymorphism at the G72/ G30 gene locus, on 13q33 are associated with bipolar disorder in two independent pedigree series.

Am J Hum Genet 2003; 72: 1131-1140.

Liu H, Heat SC, Sobin C, et al. Genetic variation at the 22q11 PRODH2 / DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci USA 2002; 99:3717-3722

Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio facial syndrome. Arch Gen Psychiatry 1999; 56: 940-945.

Murphy KC. Schizophrenia and velo-cardio facial syndrome. Lancet 2002; 359 :426-430.

Shifman S, Bronstein M, Sternfield M, et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002; 71:1926-1302.

Mirnics K, Middleton F, Marquez A. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in the prefrontal cortex. Neuron 2000; 28:53-67.

Brustowics L, Hodgkinson K, Chow E. Location of major susceptibility locus for familial schizophrenia in chromosome 1q21-q22. Science 2000; 288: 678-682.

Wong AH, Buckle CE, Van Tol HH. Polymorphism in dopamine receptors: what do they tell us? Eur J Pharmacol 2000; 410: 183-203.

Baron M. Genetics of schizophrenia and the new millennium: progress and pitfalls. Am J Hum Genet 200l; 68; 299-312.

Schiffer HH. Glutamate receptor gene: susceptibility factors in schizophrenia and depressive disorders?. Mol Neurobiol 20002; 25:191-212.

Tachikawa H, Harada S, Kawanishi Y, et al. Linked polymorphisms (-333G > T and –286A > G) in the promoter region of the CCK-A receptor gene may be associated with schizophrenia. Psychiatry Res 2001;103:147-155

Levison DF. Molecular genetics of schizophrenia: a review of the recent literature. Curr Opin psychiatry 2003; 16:157-170.

Tuulio-Henriksson A, Haukka J, Partonen T, et al. Heritability and number of quantitative trait loci of neurocognitive functions in families with schizophrenia. Am J Med Genet 2002; 114: 483-490

Narr KL, Cannon TD, Woods RP, et al. Genetic contributions to altered callosal morphology in schizophrenia. J Neurosci 2002; 22: 3720-3729.

Egan MF, Hyde TM, Bonomo JB, et al. Relatives risk of neurological signs in siblings of patients with schizophrenia. Am J Psychiatry 2001; 158: 1827-1834.

Cardno AG, Sham PC, Farmer AE, et al. Heritabilty of Schneider’s first-rank symptoms. Br J Psychiatry 2002; 180:35-38.

The International HapMap consortium. Nature 2003; 426: 789-793.

Repository Staff Only: item control page